TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. Biosimilars Market
United States and United States Biosimilars Market Report & Forecast 2023-2028

United States and United States Biosimilars Market Report & Forecast 2023-2028

  • Category:Life Sciences
  • Published on : 03 May 2023
  • Pages :128
  • Formats:
  • Report Code:SMR-7678741
OfferClick for best price

Best Price: $3480

Biosimilars Market Size, Share 2023


The United States Biosimilars market is projected to grow from US$ billion in 2023 to US$ billion by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

This report contains market size and forecasts of Biosimilars in global, including the following market information:

United States Biosimilars Market Revenue, 2018-2023, 2023-2032, ($ millions)

United States Biosimilars Market Sales, 2018-2023, 2023-2032,

United States top five Biosimilars companies in 2022 (%)

The United States Biosimilars market was valued at million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.

Report Includes

This report presents an overview of United States market for Biosimilars , sales, revenue and price. Analyses of the United States market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2032.

This report focuses on the Biosimilars sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the United States Biosimilars market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.

This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Sales Channels, sales, revenue, and price, from 2018 to 2032. Evaluation and forecast the market size for Humidifier sales, projected growth trends, production technology, sales channels and end-user industry.

Segment by Type

Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)

Recombinant Glycosylated Proteins

Segment by Applications

Oncology

Blood Disorders

Growth Hormonal Deficiency

Chronic and Autoimmune Disorders

Others

Key Companies covered in this report:

  • Company 1

  • Company 2

  • Company 3

  • Company 4

  • Company 5

  • Company 6

  • Company 7

  • Company 8

  • Company 9

  • Company 10

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Biosimilars revenues share in global market, 2022 (%)

Key companies Biosimilars sales in global market, 2018-2023 (Estimated),

Key companies Biosimilars sales share in global market, 2022 (%)

Report Attributes Report Details
Report Title United States and United States Biosimilars Market Report & Forecast 2023-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 128 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 STUDY COVERAGE
1.1 Biosimilars Product Introduction
1.2 Market by Type
1.2.1 United States Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Type1
1.2.3 Type2
1.3 Market by Application
1.3.1 United States Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Application 1
1.3.3 Application 2
1.4 United States Biosimilars Sales Estimates and Forecasts 2017-2028
1.5 United States Biosimilars Hydrocephalus Shunts Revenue Estimates and Forecasts 2017-2028
1.6 Study Objectives
1.7 Years Considered

2 COMPETITION BY MANUFACTURERS
2.1 United States Biosimilars Sales by Manufacturers
2.1.1 United States Biosimilars Sales by Manufacturers (2017-2022)
2.1.2 United States Biosimilars Sales Market Share by Manufacturers (2017-2022)
2.1.3 Top Largest Manufacturers of Biosimilars in 2021 in United States
2.2 United States Biosimilars Revenue by Manufacturers
2.2.1 United States Biosimilars Revenue by Manufacturers (2017-2022)
2.2.2 United States Biosimilars Revenue Market Share by Manufacturers (2017-2022)
2.2.3 United States Top Companies by Biosimilars Revenue in 2021
2.3 United States Biosimilars Sales Price by Manufacturers (2017-2022)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
2.4.2 United States Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Biosimilars Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans

3 UNITED STATES Biosimilars MARKET SIZE BY REGION
3.1 Biosimilars Market Size by Region: 2017-2028
3.1.1 United States Biosimilars Sales by Region: 2017-2022
3.1.2 United States Biosimilars Sales Forecast by Region (2023-2028)
3.1.3 United States Biosimilars Revenue by Region: 2017-2022
3.1.4 United States Biosimilars Revenue Forecast by Region (2023-2028)
3.2 Northeast Biosimilars Sales and Revenue Growth (2017-2028)
3.3 South Biosimilars Sales and Revenue Growth (2017-2028)
3.4 Midwest Biosimilars Sales and Revenue Growth (2017-2028)
3.5 West Biosimilars Sales and Revenue Growth (2017-2028)

4 MARKET SIZE BY TYPE
4.1 United States Biosimilars Sales by Type
4.1.1 United States Biosimilars Historical Sales by Type (2017-2022)
4.1.2 United States Biosimilars Forecasted Sales by Type (2023-2028)
4.1.3 United States Biosimilars Sales Market Share by Type (2017-2028)
4.2 United States Biosimilars Revenue by Type
4.2.1 United States Biosimilars Historical Revenue by Type (2017-2022)
4.2.2 United States Biosimilars Forecasted Revenue by Type (2023-2028)
4.2.3 United States Biosimilars Revenue Market Share by Type (2017-2028)
4.3 United States Biosimilars Price by Type
4.3.1 United States Biosimilars Price by Type (2017-2022)
4.3.2 United States Biosimilars Price Forecast by Type (2023-2028)

5 MARKET SIZE BY APPLICATION
5.1 United States Biosimilars Sales by Application
5.1.1 United States Biosimilars Historical Sales by Application (2017-2022)
5.1.2 United States Biosimilars Forecasted Sales by Application (2023-2028)
5.1.3 United States Biosimilars Sales Market Share by Application (2017-2028)
5.2 United States Biosimilars Revenue by Application
5.2.1 United States Biosimilars Historical Revenue by Application (2017-2022)
5.2.2 United States Biosimilars Forecasted Revenue by Application (2023-2028)
5.2.3 United States Biosimilars Revenue Market Share by Application (2017-2028)
5.3 United States Biosimilars Price by Application
5.3.1 United States Biosimilars Price by Application (2017-2022)
5.3.2 United States Biosimilars Price Forecast by Application (2023-2028)

6 CORPORATE PROFILE
6.1 Company1
6.1.1 Company 1 Corporation Information
6.1.2 Company 1 Overview
6.1.3 Company 1 in United States: Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
6.1.4 Company 1 Biosimilars Product Introduction
6.1.5 Company 1 Recent Developments
6.2 Company 2
6.2.1 Company 2 Corporation Information
6.2.2 Company 2 Overview
6.2.3 Company 2 in United States: Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
6.2.4 Company 2 Biosimilars Product Introduction
6.2.5 Company 2 Recent Developments
6.3 Company 3
6.3.1 Company 3 Corporation Information
6.3.2 Company 3 Overview
6.3.3 Company 3 in United States: Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
6.3.4 Company 3 Biosimilars Product Introduction
6.3.5 Company 3 Recent Developments
6.4 Company 3
6.4.1 Company 4 Corporation Information
6.4.2 Company 4 Overview
6.4.3 Company 4 in United States: Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
6.4.4 Company 4 Biosimilars Product Introduction
6.4.5 Company 4 Recent Developments

7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Biosimilars Industry Chain Analysis
7.2 Biosimilars Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biosimilars Production Mode & Process
7.4 Biosimilars Sales and Marketing
7.4.1 Biosimilars Sales Channels
7.4.2 Biosimilars Distributors
7.5 Biosimilars Customers

8 Biosimilars MARKET DYNAMICS
8.1.1 Biosimilars Industry Trends
8.1.2 Biosimilars Market Drivers
8.1.3 Biosimilars Market Challenges
8.1.4 Biosimilars Market Restraints

9 KEY FINDINGS IN THE UNITED STATES Biosimilars STUDY

10 APPENDIX
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES



Download
Free Sample
Request
Customization
Check
Discount

REPORT PURCHASE OPTIONS

USD Single User License
USD Multi User License
USD Corporate Users License

---- OR ----

Frequently Asked Questions ?

Delivery Time

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays

  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.

  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer

  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount